Compounds > 4-butyrolactone
Page last updated: 2024-08-18

4-butyrolactone and Intestinal Neoplasms

4-butyrolactone has been researched along with Intestinal Neoplasms in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borneman, J; Cheema, AK; Dowdy, T; Fornace, AJ; Maier, I; Ruegger, PM; Schiestl, RH; Singh, R; Wang, Y1
Adlercreutz, H; Heinonen, S; Karppinen, S; Mättö, J; Mutanen, M; Oikarinen, S; Poutanen, K1
Eklund, PC; Mutanen, M; Oikarinen, SI; Pajari, AM; Sjöholm, RE; Smeds, AI1
Kawamori, T; Mori, H; Okamoto, K; Suzui, M; Tamai, Y; Tanaka, T; Torihara, M; Yamahara, J1
Jinlong, G; Mori, H; Morishita, Y; Sugie, S; Tamai, Y; Tanaka, T; Torihara, M; Yamahara, J; Yoshimi, N1

Other Studies

5 other study(ies) available for 4-butyrolactone and Intestinal Neoplasms

ArticleYear
Chemopreventive Metabolites Are Correlated with a Change in Intestinal Microbiota Measured in A-T Mice and Decreased Carcinogenesis.
    PloS one, 2016, Volume: 11, Issue:4

    Topics: 4-Butyrolactone; Adenine; Animals; Cell Transformation, Neoplastic; Gastrointestinal Microbiome; Intestinal Neoplasms; Mice; Mice, Knockout

2016
Plasma enterolactone or intestinal Bifidobacterium levels do not explain adenoma formation in multiple intestinal neoplasia (Min) mice fed with two different types of rye-bran fractions.
    The British journal of nutrition, 2003, Volume: 90, Issue:1

    Topics: 4-Butyrolactone; Animals; Bifidobacterium; Dietary Fiber; Genes, APC; Intestinal Neoplasms; Intestine, Large; Lignans; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Models, Animal; Plant Extracts; Random Allocation; Secale

2003
The plant lignans matairesinol and secoisolariciresinol administered to Min mice do not protect against intestinal tumor formation.
    Cancer letters, 2006, Feb-28, Volume: 233, Issue:2

    Topics: 4-Butyrolactone; Adenomatous Polyposis Coli Protein; Animals; Butylene Glycols; Diet; Disease Models, Animal; Female; Furans; Intestinal Neoplasms; Lignans; Male; Mice; Mice, Inbred C57BL; Plants

2006
Chemoprevention of azoxymethane-induced intestinal carcinogenesis by a novel synthesized retinoidal butenolide, 5-hydroxy-4-(2-phenyl-(E)-ethenyl)-2(5H)-furanone, in rats.
    Carcinogenesis, 1995, Volume: 16, Issue:4

    Topics: 4-Butyrolactone; Animals; Anticarcinogenic Agents; Antineoplastic Agents; Azoxymethane; Biomarkers, Tumor; Bromodeoxyuridine; Colon; Dose-Response Relationship, Drug; Epithelium; Intestinal Neoplasms; Male; Ornithine Decarboxylase; Precancerous Conditions; Rats; Rats, Inbred F344; Retinoids

1995
Inhibitory effect of 5-hydroxy-4-(2-phenyl-(E)-ethenyl)-2(5H)-furanone, a novel synthesized retinoid, on azoxymethane-induced intestinal carcinogenesis in rats.
    Cancer letters, 1992, Sep-30, Volume: 66, Issue:2

    Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Azoxymethane; Intestinal Neoplasms; Male; Rats; Rats, Inbred F344; Retinoids

1992